Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel A Ferrer

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Reumatologia Clinica|September 6, 2017
Rituximab in refractory autoimmune hemolytic anemia in systemic lupus erythematosusMaría Pavo-Blanco, Marta Novella-Navarro, Rafael Cáliz-Cáliz, et al.
Human Movement Science|July 28, 2017
Myoelectronic signal-based methodology for the analysis of handwritten signaturesCristina Carmona-Duarte, Rafael de Torres-Peralta, Moises Diaz, et al.
IEEE Transactions on Cybernetics|September 30, 2017
Static and Dynamic Synthesis of Bengali and Devanagari SignaturesMiguel A Ferrer, Sukalpa Chanda, Moises Diaz, et al.
Pharmacogenetics and Genomics|April 9, 2015
Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs: a multicenter studyLuz M Canet, Ileana Filipescu, Rafael Cáliz, et al.
Pharmacogenetics and Genomics|June 26, 2015
Genetic variants within immune-modulating genes influence the risk of developing rheumatoid arthritis and anti-TNF drug response: a two-stage case-control studyLuz M Canet, Rafael Cáliz, Carmen B Lupiañez, et al.
Scientific Reports|March 11, 2020
NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortiumJose Manuel Sánchez-Maldonado, Manuel Martínez-Bueno, Helena Canhão, et al.
Frontiers in Immunology|November 15, 2021
Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large CohortsJose Manuel Sánchez-Maldonado, Rafael Cáliz, Miguel Ángel López-Nevot, et al.
The Pharmacogenomics Journal|October 6, 2018
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patientsLuz M Canet, Jose M Sánchez-Maldonado, Rafael Cáliz, et al.
The Pharmacogenomics Journal|February 15, 2019
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patientsLuz M Canet, Jose M Sánchez-Maldonado, Rafael Cáliz, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Reumatologia Clinica|September 6, 2017
Rituximab in refractory autoimmune hemolytic anemia in systemic lupus erythematosusMaría Pavo-Blanco, Marta Novella-Navarro, Rafael Cáliz-Cáliz, et al.
Human Movement Science|July 28, 2017
Myoelectronic signal-based methodology for the analysis of handwritten signaturesCristina Carmona-Duarte, Rafael de Torres-Peralta, Moises Diaz, et al.
IEEE Transactions on Cybernetics|September 30, 2017
Static and Dynamic Synthesis of Bengali and Devanagari SignaturesMiguel A Ferrer, Sukalpa Chanda, Moises Diaz, et al.
Pharmacogenetics and Genomics|April 9, 2015
Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs: a multicenter studyLuz M Canet, Ileana Filipescu, Rafael Cáliz, et al.
Pharmacogenetics and Genomics|June 26, 2015
Genetic variants within immune-modulating genes influence the risk of developing rheumatoid arthritis and anti-TNF drug response: a two-stage case-control studyLuz M Canet, Rafael Cáliz, Carmen B Lupiañez, et al.
Scientific Reports|March 11, 2020
NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortiumJose Manuel Sánchez-Maldonado, Manuel Martínez-Bueno, Helena Canhão, et al.
Frontiers in Immunology|November 15, 2021
Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large CohortsJose Manuel Sánchez-Maldonado, Rafael Cáliz, Miguel Ángel López-Nevot, et al.
The Pharmacogenomics Journal|October 6, 2018
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patientsLuz M Canet, Jose M Sánchez-Maldonado, Rafael Cáliz, et al.
The Pharmacogenomics Journal|February 15, 2019
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patientsLuz M Canet, Jose M Sánchez-Maldonado, Rafael Cáliz, et al.
Pageof 2